Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis

Saved in:
Bibliographic Details
Main Authors: Jarr, Kai-Uwe (Author) , Palm, Kaylin C.A. (Author) , Pasterkamp, Gerard (Author) , Mokry, Michal (Author) , Leeper, Nicholas J. (Author)
Format: Article (Journal) Editorial
Language:English
Published: 22 July 2025
In: Circulation
Year: 2025, Volume: 152, Issue: 3, Pages: 208-211
ISSN:1524-4539
DOI:10.1161/CIRCULATIONAHA.124.072676
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/CIRCULATIONAHA.124.072676
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072676
Get full text
Author Notes:Kai-Uwe Jarr, MD, Kaylin C.A. Palm, MS, Gerard Pasterkamp, MD, PhD, Michal Mokry, MD, PhD, and Nicholas J. Leeper, MD, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1942473168
003 DE-627
005 20251126160405.0
007 cr uuu---uuuuu
008 251125s2025 xx |||||o 00| ||eng c
024 7 |a 10.1161/CIRCULATIONAHA.124.072676  |2 doi 
035 |a (DE-627)1942473168 
035 |a (DE-599)KXP1942473168 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jarr, Kai-Uwe  |d 1984-  |e VerfasserIn  |0 (DE-588)1067200088  |0 (DE-627)818416890  |0 (DE-576)426445066  |4 aut 
245 1 0 |a Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis  |c Kai-Uwe Jarr, MD, Kaylin C.A. Palm, MS, Gerard Pasterkamp, MD, PhD, Michal Mokry, MD, PhD, and Nicholas J. Leeper, MD, PhD 
264 1 |c 22 July 2025 
300 |b Illustrationen 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 21. Juli 2025 
500 |a Gesehen am 25.11.2025 
700 1 |a Palm, Kaylin C.A.  |e VerfasserIn  |4 aut 
700 1 |a Pasterkamp, Gerard  |e VerfasserIn  |4 aut 
700 1 |a Mokry, Michal  |e VerfasserIn  |4 aut 
700 1 |a Leeper, Nicholas J.  |e VerfasserIn  |0 (DE-588)1379114381  |0 (DE-627)1938548302  |4 aut 
773 0 8 |i Enthalten in  |t Circulation  |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950  |g 152(2025), 3 vom: Juli, Seite 208-211  |h Online-Ressource  |w (DE-627)265784670  |w (DE-600)1466401-X  |w (DE-576)074891189  |x 1524-4539  |7 nnas  |a Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis 
773 1 8 |g volume:152  |g year:2025  |g number:3  |g month:07  |g pages:208-211  |g extent:4  |a Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis 
856 4 0 |u https://doi.org/10.1161/CIRCULATIONAHA.124.072676  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072676  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251125 
993 |a Editorial 
994 |a 2025 
998 |g 1067200088  |a Jarr, Kai-Uwe  |m 1067200088:Jarr, Kai-Uwe  |d 910000  |d 910100  |e 910000PJ1067200088  |e 910100PJ1067200088  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1942473168  |e 4813449603 
BIB |a Y 
SER |a newspaper 
JSO |a {"language":["eng"],"name":{"displayForm":["Kai-Uwe Jarr, MD, Kaylin C.A. Palm, MS, Gerard Pasterkamp, MD, PhD, Michal Mokry, MD, PhD, and Nicholas J. Leeper, MD, PhD"]},"note":["Zuerst veröffentlicht: 21. Juli 2025","Gesehen am 25.11.2025"],"person":[{"display":"Jarr, Kai-Uwe","given":"Kai-Uwe","family":"Jarr","role":"aut"},{"given":"Kaylin C.A.","display":"Palm, Kaylin C.A.","role":"aut","family":"Palm"},{"display":"Pasterkamp, Gerard","given":"Gerard","role":"aut","family":"Pasterkamp"},{"display":"Mokry, Michal","given":"Michal","family":"Mokry","role":"aut"},{"family":"Leeper","role":"aut","display":"Leeper, Nicholas J.","given":"Nicholas J."}],"recId":"1942473168","id":{"eki":["1942473168"],"doi":["10.1161/CIRCULATIONAHA.124.072676"]},"physDesc":[{"noteIll":"Illustrationen","extent":"4 S."}],"title":[{"title":"Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis","title_sort":"Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosis"}],"type":{"bibl":"article-newspaper","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"22 July 2025","dateIssuedKey":"2025"}],"relHost":[{"language":["eng"],"part":{"year":"2025","volume":"152","pages":"208-211","extent":"4","issue":"3","text":"152(2025), 3 vom: Juli, Seite 208-211"},"pubHistory":["1.1950 -"],"note":["Gesehen am 10.10.2025"],"type":{"media":"Online-Ressource","bibl":"newspaper"},"disp":"Computational modeling predicts benefits of proefferocytic therapy in human atherosclerosisCirculation","corporate":[{"role":"isb","display":"American Heart Association"}],"recId":"265784670","title":[{"title_sort":"Circulation","subtitle":"an official journal of the American Heart Association","title":"Circulation"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["265784670"],"issn":["1524-4539"],"zdb":["1466401-X"]},"origin":[{"dateIssuedKey":"1950","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-"}]}]} 
SRT |a JARRKAIUWECOMPUTATIO2220